NATIONAL PRESTO INDUSTRIES INC financial statements

Income statement, balance sheet and cash flow statement for the last 10 fiscal years, taken from the XBRL data NATIONAL PRESTO INDUSTRIES INC files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	342	334	323	309	353	356	322	341	388	504
Cost of revenue	256	246	247	237	268	291	266	273	310	423
Gross profit	85.7	87.2	75.9	71.9	84.9	64.4	55.1	67.5	78.6	80.3
Selling, general and administrative	22.4	22.9	23.3	25.5	28.5	34.2	27.1	30.8	31.8	35.9
Operating income	62.5	61.7	47.9	46.4	56.2	30	22.1	35	45.2	40.2
Other non-operating income	0.81	3.58	4.44	5.93	3.79	2.43	3.82	7.4	5.46	1.88
Pre-tax income	63.3	65.3	52.3	52.3	60	32.5	25.9	42.4	50.7	42.1
Income tax	21.4	22	12.5	11.8	13	6.81	5.25	7.87	9.21	9.04
Income from continuing operations			39.9	40.5	47	25.7
Net income	44.6	53	39.9	42.2	47	25.7	20.7	34.6	41.5	33.1
EBITDA	71.4	71.5	54.1	50.1	59.2	33	25.1	41	48.7	43.9
EPS, basic	6.39	7.58	5.70	6.02	6.67	3.63	2.92	4.86	5.82	4.63
EPS, diluted	6.39	7.58	5.70	6.02	6.67	3.63	2.92	4.86	5.82	4.63
Shares, basic (weighted)	6.97	6.99	7.01	7.02	7.04	0.01	0.01	7.11	7.13	7.15
Shares, diluted (weighted)	6.97	6.99	7.01	7.02	7.04	7.06	0.01	7.11	7.13	7.15

Balance sheet

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	27	11.2	56.8	79.6	86	110	70.7	87.7	17.7	3.25
Short-term investments	84.5	144	135	78.7	69	34.2	24.9	26.5	5.01	0.5
Receivables	67.3	65.2	52.4	41.5	53.7	53.4	71	48.7	62.3	85
Inventory	95.4	104	94	129	135	144	152	190	278	307
Other current assets	7.42	7.19	6.87	6.67	10.2	4.49	5.67	5.22	3.1	3.13
Total current assets	340	339	352	338	357	348	327	360	367	403
Property, plant and equipment	49.5	45.2	39.1	37.3	37.1	36.7	41.8	39.2	43.2	63.9
Lease right-of-use assets				3.52	3.36	10.2	10.7	10.7	9.96	9.44
Goodwill	11.5	11.5	11.5	15.3	15.3	15.3	18.6	19.4	19.4	19.4
Intangible assets	4.96	3.33	1	3.06	2.84	2.62	6.93	5.29	3.78	2.26
Other non-current assets	4.64	5.64	1.67	4.78	6.91	2.88	1.69	0
Total assets	418	412	414	410	433	420	412	441	453	501
Accounts payable	39.6	28.4	34.1	21.7	33.5	32.8	28.9	32.6	44.6	46
Accrued liabilities	12.2	13.1	12	13.3	16.3	16.7	21.6	36.2	24.6	24.9
Deferred revenue							5.66	13.7	7.35	9.23
Total current liabilities	64.4	45.5	47.5	39.3	55.1	53.2	53.6	72	74.4	95
Lease liabilities				3	2.79	9.62	10.2	9.99	9.4	8.93
Other non-current liabilities				0	0.94	7.44	7.44	7.44	7.44
Total liabilities	67.4	45.5	47.5	42.3	58.8	62.8	63.8	84.3	85.8	106
Paid-in capital	7.91	9.07	10.4	11.4	12.4	13.7	14.8	16	17.3	18.4
Retained earnings	350	365	363	363	368	349	338	344	354	380
Treasury stock	-15.3	-14.8	-14.4	-13.9	-13.3	-12.8	-12.2	-11.5	-10.8	-10.3
Other comprehensive income	-0.05	-0.09	0.02	0.14	0.15	0.02	-0.1	0.02	0.04	0.01
Shareholders' equity	350	366	366	368	374	358	348	356	368	395
Total equity	350	366	366	368	374	358	348	356	368	395
Total liabilities and equity	418	412	414	410	433	420	412	441	453	501
Shares outstanding	6.95	6.97	6.98	7.01	7.03	7.04	7.06	7.08	7.11	7.12

Cash flow statement

	FY2016	FY2017	FY2018	FY2019	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	44.6	53	39.9	42.2	47	25.7	20.7	34.6	41.5	33.1
Depreciation and amortization	8.88	9.84	6.22	3.69	3.01	2.98	2.98	6.01	3.53	3.62
Stock-based compensation	0.39	0.55	0.47	0.83	0.37	0.47	0.48	0.61	0.49	0.58
Deferred income tax	6.36	-4	-0.12	-0.22	-1.72	-1.61	-2.31	-1.19	-4.53	7.74
Change in receivables	-13.5	1.85	11.5	10.9	-12.2	1.08	-12.9	20.3	-13.3	-22.9
Change in inventory	-7.53	-8.73	6.82	-34.2	-6.95	-10.1	-5.62	-38.6	-87.6	-29
Change in payables	12.1	-11.5	6.07	-11.6	15.7	-1.23	-0.68	18.3	0.39	1.73
Cash from operations	66.4	24.3	76.2	9.58	41	34.7	8.77	45.4	-53.4	-9.14
Capital expenditures	-6.95	-7.4	-8.69	-3.14	-2.62	-2.87	-1.03	-1.84	-7.53	-27
Acquisitions			0	-3.73	0	0	-24.7	0	0
Purchases of investments	-86.1	-193	-163	-105	-48	-3.92	-20	-47.7	-5.43	0
Cash from investing	-60.8	-2.09	10.8	55.2	7.16	32.5	-16.4	-0.45	15	-21.9
Dividends paid	-35.2	-38.4	-42	-42.1	-42.2	-44.1	-31.8	-28.4	-32	-7.14
Cash from financing	-34.7	-38	-41.5	-42	-41.7	-43.5	-31.4	-28	-31.5	16.6
Net change in cash	-29.2	-15.8	45.6	22.7	6.46	23.8	-39.1	16.9	-70	-14.4
Free cash flow	59.4	16.9	67.6	6.45	38.4	31.8	7.74	43.5	-61	-36.2
Interest paid							0	0	0	0.83
Income taxes paid	17.3	32.8	15	10.2	13.8	10.1	8.21	6.84	12	10.2

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to July 5, 2026; growth uses fiscal years. Valuation uses the share price of $144.66 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	16.5%	Gross profit / revenue.
Operating margin	9.6%	Operating income / revenue.
EBITDA margin	10.4%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	10.0%	Pre-tax income / revenue.
Net margin	7.9%	Net income / revenue.
FCF margin	4.9%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	6.1%	Cash from operations / revenue.
Effective tax rate	21.5%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	10.4%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	8.6%	Net income / average total assets.
Return on invested capital (ROIC)	10.4%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
SG&A / revenue	6.8%	Selling, general and administrative expense / revenue.
Capex / revenue	1.3%	Capital expenditures / revenue.
D&A / revenue	0.7%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	29.7%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	16.1%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	7.4%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	2.2%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	13.4%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	-1.1%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	-11.0%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	22.1%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	-6.5%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	-10.0%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	20.4%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	-5.8%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	-20.2%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	16.9%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	-6.8%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	-20.4%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	16.6%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	-7.0%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	7.5%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	4.3%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	1.1%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	10.4%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	6.7%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	2.9%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	0.3%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	903.1%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	0.3%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	5.22x	Current assets / current liabilities.
Quick ratio	0.21x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	0.21x	(Cash + short-term investments) / current liabilities.
Liabilities / assets	17.5%	Total liabilities / total assets.
Working capital	$324.6M	Current assets - current liabilities.
Goodwill and intangibles / assets	4.2%	(Goodwill + intangible assets) / total assets.
Tangible book value	$390.4M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	1.09x	Revenue / average total assets.
Fixed asset turnover	8.45x	Revenue / average property, plant and equipment.
Inventory turnover	1.39x	Cost of revenue / average inventory.
Days inventory	262 days	365 x average inventory / cost of revenue.
Days payables	34 days	365 x average accounts payable / cost of revenue.
FCF conversion	61.7%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	21.0%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$5.98	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$75,998.00	Revenue / diluted weighted shares.
FCF per share	$3,688.00	Free cash flow / diluted weighted shares.
Operating cash flow per share	$4,669.00	Cash from operations / diluted weighted shares.
Book value per share	$57,384.00	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	$54,479.00	Tangible book value / shares outstanding.
Cash per share	$2,273.00	(Cash + short-term investments) / shares outstanding.
Payout ratio	16.7%	Dividends paid / net income, when net income is positive.
Dividends / FCF	27.1%	Dividends paid / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$1.03B	Share price x shares outstanding.
Enterprise value	$1.02B	Market cap + total debt - cash - short-term investments.
P/E	24.1x	Market cap / net income. Only when net income is positive.
P/S	1.90x	Market cap / revenue.
P/B	2.51x	Market cap / shareholders' equity. Only when equity is positive.
Price / tangible book	2.64x	Market cap / tangible book value, when positive.
P/FCF	39.1x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	30.8x	Market cap / cash from operations, when positive.
EV/Sales	1.87x	Enterprise value / revenue.
EV/EBIT	19.3x	Enterprise value / operating income, when both are positive.
EV/EBITDA	18.0x	Enterprise value / EBITDA, when both are positive.
EV/FCF	38.4x	Enterprise value / free cash flow, when both are positive.
FCF yield	2.6%	Free cash flow / market cap.
Earnings yield	4.1%	Net income / market cap (the inverse of P/E).
Dividend yield	0.7%	Dividends paid over the period / market cap.
Shareholder yield	0.7%	(Dividends paid + share buybacks) / market cap.
PEG	1.45x	P/E / EPS growth per year over 3 years (in percent). Only when both are positive.

What was NATIONAL PRESTO INDUSTRIES INC's revenue in fiscal 2025?

NATIONAL PRESTO INDUSTRIES INC reported revenue of $503.5M for fiscal 2025, 29.7% higher than the year before.

Was NATIONAL PRESTO INDUSTRIES INC profitable in fiscal 2025?

Yes. Net income was $33.1M, a net margin of 6.6%.

How much free cash flow did NATIONAL PRESTO INDUSTRIES INC generate in fiscal 2025?

Cash from operations of $9.1M minus capital expenditures of $27.0M left free cash flow of -$36.2M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to NATIONAL PRESTO INDUSTRIES INC